Michael Mont, MD
Adult Reconstructive Orthopaedic Surgery · Baltimore, MDNPI 1679516751
Payments from drug & device makers
Across 586 payments — averaging $19,286 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$10.2M
- Pacira Pharmaceuticals Incorporated$268K
- Ethicon Endo-surgery Inc.$263K
- Next Science LLC$202K
- Johnson & Johnson$192K
- Pacira Therapeutics, Inc.$50K
- plus $168K from 18 others
Across 14 payments — averaging $1372.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- DJO, LLC$10K
- Pfizer$7K
- Regeneron$2K
What the payments were for
- Royalty or licence$8,427,21277%
- Consulting fees$2,456,65322%
- Speaking & faculty fees$9,2800%
- Travel & lodging$40,5330%
- Food & beverage$10,9070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 430 | $10,156,973 |
| Pacira Pharmaceuticals Incorporated | 24 | $268,393 |
| Ethicon Endo-surgery Inc. | 12 | $263,395 |
| Next Science LLC | 14 | $202,168 |
| Johnson & Johnson(3 entities) | 40 | $192,089 |
| Pacira Therapeutics, Inc. | 3 | $50,406 |
| Regeneron | 20 | $41,862 |
| KCI USA, Inc. | 7 | $26,152 |
| Lilly USA, LLC | 3 | $17,400 |
| Exactech, Inc. | 11 | $17,289 |
| Motive Health, Inc. | 1 | $16,500 |
| Ferring Pharmaceuticals Inc. | 1 | $15,000 |
| Encore Medical, LP | 1 | $10,000 |
| Solventum Corporation | 1 | $6,350 |
| Eli Lilly | 1 | $5,800 |
| Medical Device Business Services, Inc. | 6 | $4,381 |
| Argenx US, Inc. | 1 | $3,750 |
| Innocoll Pharmaceuticals Limited | 1 | $2,600 |
| Microport Orthopedics Inc | 3 | $461 |
| Pfizer | 1 | $330 |
| Davol Inc. | 2 | $157 |
| Orthofix Medical, Inc. | 1 | $119 |
| Kuros Biosciences USA, Inc | 1 | $107 |
| DJO, LLC | 1 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCOLADE$8,442,332
- TRIATHLON$5,889,457
- TRIDENT$5,604,693
- MAKO$1,218,924
- STRATAFIX$454,465
- DERMABOND PRINEO$289,135
- REUNION$209,500
- Zilretta$168,951
- DERMABOND Portfolio$159,390
- MONOCRYL$99,715
- EXPAREL$98,424
- SurgX$76,122
- Xperience$76,122
- Iovera$42,769
- PREVENA$32,412
- Bair Hugger$25,000
- 3M DuraPrep Surgical$25,000
- Ioban$25,000
- 3M Skin and Nasal Antiseptic$25,000
- INSIGNIA$25,000
How this compares
$11,301,760 in reported general payments places this provider in the 95th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.
See all adult reconstructive orthopaedic surgery providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult reconstructive orthopaedic surgery in Baltimore
- James NaceBaltimore$340K
- Pablo WagnerBaltimore$118K
- Mark HasenauerBaltimore$35K
- Gregory MendezBaltimore$10K
- Marissa BonyunBaltimore$8K
- Robert McKinstryBaltimore$4K
- Grant DuvallBaltimore$3K
- Peter JayBaltimore$114
- Randal LewisChevy Chase$2.6M
- Sridhar DurbhakulaBethesda$874K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.